Harbin Gloria Pharma to Pay $27.5 Million for Stake in Zhenyang Hospital

Harbin Gloria Pharma will acquire a 70% interest in Sheyang Zhenyang Hospital (Sheyang branch of Second Affiliated Hospital of Nanjing Medical University) for at least $27.5 million. Hospital management is a new field for Gloria, which is known as a maker of injectible drugs. Gloria is treating the acquisition as a test case: if the purchae proves profitable, Gloria will seek to build a portfolio of China hospitals. More details.... Stock Symbol: (SHZ: 002437) Share this with colleagues: // //